The hepatitis B virus is 42 nm in diameter and contains DNA. Reports of the isolation of a cross reacting variant, hepatitis B virus type 2, have not yet been verified. It is plasma borne and easily transmitted by all blood components and most blood products (for example, factor VIII). It is not transmitted by pasteurised albumin. The chance of transmission is enhanced when plasma is pooled for the manufacture of blood products. The incubation period ranges from two to six months but is usually about four. Although it is extremely infectious when injected and is resistant to both chemical and heat inactivation, the number of transfusion transmitted cases has been drastically reduced by screening and the few that do occur are usually caused by pooled plasma products. Inactivation of pooled plasma products may reduce this even further. HIV-I was transmitted by transfusion before screening was introduced and before donors at high risk started excluding themselves from giving blood. HIV-II occurs mainly in west Africa. Both are retroviruses 100 nm in diameter that carry their own RNA dependent DNA polymerase (reverse transcriptase). Before screening was introduced, HIV had been transmitted by whole blood, red cell components, platelet concentrates, and fresh frozen plasma. It can contaminate factor VIII and factor IX concentrates, but it is inactivated by heat and chemicals. It has not been transmitted by albumin, immunoglobulins, or antithrombin III. The length of time before seroconversion is rarely longer than three months, and a primary illness similar to glandular fever may occur. The incubation period for AIDS is variable, with a likely median time of seven years in adults (though the period is shorter for infants).
Screening for HIV antibody is by an "antiglobulin" or "competitive"' enzyme linked immunosorbent assay (ELISA), and recently latex and gelatin particle "sandwich" assays have been introduced. In most countries screening is only for antibody to HIV-I, as the incidence of HIV-II is low outside west Africa. Screening for HIV antigen is not indicated in a country with such a low prevalence as the United Kingdom, as it is unlikely that any extra infectious donors would be identified in addition to those positive for HIV antibody.
Transmission of HIV by transfusion has been extremely rare since the introduction of screening, but if it occurs in infants it leads more rapidly to serious disease than in adults. HIV antibody is found in about 1/70 000 donations in the United Kingdom, and the number is steadily decreasing. "Seroconverting" donations (those negative for HIV antibody but infectious because of recent infection) are therefore extremely rare. Only one donation from a seronegative donor is known to have transmitted HIV infection in the United Kingdom since screening started in 1985. The virus can be inactivated in blood products by treatment with heat or chemicals, but blood and blood components (for example, platelets) cannot be treated in either of these ways. There may be at least two different viruses that transmit non-A, non-B hepatitis. Recently an assay has been developed in which cloned peptides can react with antibody to the "non-B" agent that is the cause of most of the non-A, non-B hepatitis that might develop as a result of transfusion. The virus is probably plasma borne (it may also be intracellular, but we do not yet know), and it is likely to be transmitted in the same ways as hepatitis B virus. The incubation period is from two to 26 weeks, depending on the agent. The agent detected by the new test (and popularly referred to as "hepatitis C virus") seems to be of the longer incubation type.
Non-A, non-B hepatitis
Some countries (including the United States) require screening for antibody to hepatitis B core and measurement of alanine aminotransferase activity. Most donations with abnormal markers, however, do not transmit non-A, non-B hepatitis, so "surrogate" screening leads to unnecessary waste of blood donations. The principal causes of increased alanine aminotransferase activity in the United Kingdom are obesity and alcohol consumption. In addition, some donations may transmit the disease despite having normal markers. Specific screening may be possible in future; an assay for hepatitis C antibody is available, but it has not yet been introduced into the routine screening regimen in the United Kingdom.
In the United States, before screening for HIV antibody was introduced, about 10% of transfusions caused significant increases in transaminase activity in recipients, and there were occasional cases of hepatitis; this figure has now been reduced to less than 7%. There are, however, large geographical variations and rates have come down since exclusion of donors at risk of HIV infection and surrogate screening were introduced. Acute infection is usually mild, but some patients do develop chronic liver disease (though the extent and importance of this in the United Kingdom is debatable). Large prospective studies on the chronicity of non-A, non-B hepatitis that has been transmitted by transfusion are needed, particularly BMJ VOLUME'300 The possibility of obtaining a discretionary grant from a local education authority varies in different parts of the country. There does not seem to be any common theme as to which students or courses may be considered eligible. In my year at medical school two students receive a discretionary grant whereas a third does not, though all are graduates and all live within the boundaries of Birmingham Education Authority. Medical students who decide to appeal against the decision of their local education authority not to give them a grant should consult the National Union of Students, who may be able to offer some advice about the best way to pursue an appeal.
Moonlighting and borrowing
During the preclinical years of the course part time work to supplement income is a real possibility, but with progression into the clinical years the available time to "moonlight" is drastically reduced. Even so, graduate medical students such as dental surgeons and opticians are usually able to survive financially by working during their spare time. It is not as easy for graduates in non-vocational subjects whose qualification does not provide easy access to part time employment.
Inevitably, many graduates soon find that the funds of viraemia is short. The titre of virus during the period of viraemia, however, is high and infectious units of plasma can contaminate batches of factor VIII; over 90% of recipients of untreated factor VIII are likely to be seropositive. Heat treatment of freeze dried factor VIII at 80°C for 72 hours seems to inactivate the virus.
The number of infections that are potentially transmissible by blood transfusion seems daunting. In the United Kingdom, however, the incidence of most of these infections in the general population is low. Most potential donors who are at high risk have voluntarily stopped giving blood, and blood that is given is carefully screened, so the absolute numbers of infectious complications of blood transfusion are minute.
Patients are at much greater risk if they do not have transfusions when they genuinely need them than they are from the possible complications of transfusion, particularly as physicians are now more aware of the risks and more discerning in their prescriptions of blood or its components. government's proposals to introduce student loans from September 1990 represent "an important step away from the dependency culture" and added that "giving students a financial stake in their own future ... will encourage greater economic awareness and selfreliance" (press release from the Department of Education and Science, number 347, 1988) . It is not known at present what effect loans will have on the applications to medical schools, though some believe they may act as a disincentive to study medicine as it would entail relying on loans for five years or more.' Recently, the BM7 reported that the government also proposes to increase undergraduate fees for medicine from £607 currently to £3200 a year by 1991.2 The implications of the proposed increase in educational fees will mean that self financed students would have to find £16 000 for the five year undergraduate course in medicine.
I have written this article to provide guidance to prospective graduate medical students about alternative sources of funding based on my own experiences in applying to educational trusts and charities.
Discretionary grants
Currently, most undergraduate students receive a mandatory grant as a right: students studying for a second degree, however, are not entitled to one. Graduate students may sometimes receive a discretionary grant from their local education authority, though the reasons why some graduates may be funded in this way and others not do not have to be revealed by
